2Jayasundar R, Shah T, Vaishya S, Singh VP, Sarkar C. In vivo and in vitro MR spectroscopic profile of central neurocytomas[ J]. J Magn Reson Imaging,2003,17(2) :256 -260.
3Rajkumar SV, Jacobus S, Callander NS, Fonseca R, Vesole DH, Williams ME, Abonour R, Siegel DS, Katz M, Greipp PR, Eastern Cooperative Oneology Group. Lenalidomiide plus highdose dex- amethasone versus lenalidomiide plus low - dose dexamethasone as initial therapy for newly diagnosed multiple myeloma:au openlabel randomized controlled trial[ J]. Lancet Oncol,2010,11 ( 1 ) :29 - 37.
4Oken MM, Harrington DP, Abramson N, Kyle RA, Knospe W, Glick JH. Comparison of melphalan and prednisone with vincyis- tine,carmustime meiphalan,eyclophospham and prednisone in the treatment of multiple myeloma. Results of Eastern Cooperative On- cologv Study E2 479 [ J]. Cancer. 1997.79 ( 8 ) :1561 - 1567.
5Blade J, Samson D, Reece D. Creteria for evaluating disease re- sponse and progession in patients with multiple myeloma treated by high- dose therapy and haemopeietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant [ J ]. Br J Haemaol, 1998, 102 ( 10 ) : 1115 - 1123,.
6San Miguel JF, Schlag R, Khuageva NK, Dimopoulos MA, Shpil- berg O, Kropff M, Spieka I, Petrucci MT, Palumbo A, Samoilova OS, Dmoszynska A, Abdulkadyrov KM, Schots R, Jiang B, Ma- teos MV, Anderson KC, Esseltine DL, Liu K, Cakana A, van de Velde H, Richardson PG; VISTA Trial Investigators. Bortezomib plus melphalan and prednisone for initial treatment of multiple my- eloma[ J]. N Engl J Meal,2008,359(9) :906 -917.
7Abe M,Hiura K,Wilde J,et al. H.ole for maerophage inflanmatory protein(MIP) - lalpha and MIP - lbeta in the development of osteolytic lesions in muhiple myeloma[ J]. Blood,2002,100(6) :2195 -2202.
8Uneda S, Hata l-l, Matsuno F. Maerophage inflammatory protein - 1 alpha is produced by human multiple myeloma ( MM ) cells and its expression correlates with bone lesions in patients with MM [ J]. Br J Haemato1,2003,120( 1 ) :53 - 55.
9张之南,沈悌.血液病诊断及疗效标准[M].3版.北京:科学出版社,2008:232.
10Durie BG, Salmon SE. A clinical staging system for multiple myeloma: correlation of measured myeloma cell wass with presenting clinical features, response to treatment and survival[J]. Cancer, 1975, 36:842 - 854.
